Literature DB >> 11206476

Synthesis and structure--activity analysis of novel dihydropyridine derivatives to overcome multidrug resistance.

S Tasaka1, H Ohmori, N Gomi, M Iino, T Machida, A Kiue, S Naito, M Kuwano.   

Abstract

The structure activity relationships were studied on newly synthesized 1,4-dihydropyridine derivatives possessing a 1-pentyl group at the 4-position, and 3-pyridylpropylester was found to be one of the effective fragments for overcoming P-glycoprotein mediated multidrug-resistance (MDR) in cultured human cancer cells, in vitro. 3-Pyridylpropylester was also found to be one of the effective fragments for increasing the life span of P-glycoprotein overexpressing MDR P388 leukemia-bearing mice, in vivo. All compounds had weak calcium antagonistic activities, but there appeared no relationship between MDR reversing effect and calcium antagonistic activity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11206476     DOI: 10.1016/s0960-894x(00)00651-x

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  9 in total

1.  Bilayer properties of giant magnetic liposomes formed by cationic pyridine amphiphile and probed by active deformation under magnetic forces.

Authors:  O Petrichenko; K Erglis; A Cēbers; A Plotniece; K Pajuste; G Béalle; Ch Ménager; E Dubois; R Perzynski
Journal:  Eur Phys J E Soft Matter       Date:  2013-01-30       Impact factor: 1.890

2.  Diethyl 4-[5-(biphenyl-4-yl)-1H-pyrazol-4-yl]-2,6-dimethyl-1,4-dihydro-pyridine-3,5-dicarboxyl-ate ethanol monosolvate.

Authors:  Hoong-Kun Fun; Madhukar Hemamalini; A M Vijesh; Arun M Isloor; T Arulmoli
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-06-22

3.  Cytotoxic effect of some 1, 4-dihydropyridine derivatives containing nitroimidazole moiety.

Authors:  Ramin Miri; Katayoun Javidnia; Zahra Amirghofran; Seyyed Hossein Salimi; Zahra Sabetghadam; Savis Meili; Ahmad Reza Mehdipour
Journal:  Iran J Pharm Res       Date:  2011       Impact factor: 1.696

4.  Design, Synthesis and Anti-Tubercular Activity of Novel 1, 4-Dihydropyrine-3, 5-Dicarboxamide Containing 4(5)-Chloro-2-Ethyl- 5(4)-Imidazolyl Moiety.

Authors:  Maryam Iman; Asghar Davood; Mahboubeh Lotfinia; Golnoush Dehqani; Soroush Sardari; Parisa Azerang; Mohsen Amini
Journal:  Iran J Pharm Res       Date:  2016       Impact factor: 1.696

5.  Dihydropyridine Derivatives as Cell Growth Modulators In Vitro.

Authors:  Imanta Bruvere; Egils Bisenieks; Janis Poikans; Janis Uldrikis; Aiva Plotniece; Karlis Pajuste; Martins Rucins; Brigita Vigante; Zenta Kalme; Marina Gosteva; Ilona Domracheva; Astrida Velena; Tea Vukovic; Lidija Milkovic; Gunars Duburs; Neven Zarkovic
Journal:  Oxid Med Cell Longev       Date:  2017-04-03       Impact factor: 6.543

6.  Bactericidal and immunomodulatory properties of magnetic nanoparticles functionalized by 1,4-dihydropyridines.

Authors:  Katarzyna Niemirowicz-Laskowska; Katarzyna Głuszek; Ewelina Piktel; Karlis Pajuste; Bonita Durnaś; Grzegorz Król; Agnieszka Z Wilczewska; Paul A Janmey; Aiva Plotniece; Robert Bucki
Journal:  Int J Nanomedicine       Date:  2018-06-11

7.  Synthesis of novel 1,8-acridinediones derivatives: Investigation of MDR reversibility on breast cancer cell lines T47D and tamoxifen-resistant T47D.

Authors:  S A Moallem; N Dehghani; S Mehri; Sh Shahsavand; M Alibolandi; F Hadizadeh
Journal:  Res Pharm Sci       Date:  2015 May-Jun

8.  Oxidative Aromatization, Cytotoxic Activity Evaluation and Conformational Study of Novel 7-aryl-10, 11-dihydro-7H-chromeno [4, 3-b]quinoline-6, 8(9H, 12H)-dione Derivatives.

Authors:  Radineh Motamedi; Abbas Shafiee; Mohammad Reza Rezai; Omidreza Firuzi; Najmeh Edraki; Ramin Miri
Journal:  Iran J Pharm Res       Date:  2014       Impact factor: 1.696

9.  Design, Synthesis and Evaluation of Antitubercular Activity of Novel Dihydropyridine Containing Imidazolyl Substituent.

Authors:  Maryam Iman; Asghar Davood; Golnoush Dehqani; Mahboubeh Lotfinia; Soroush Sardari; Parisa Azerang; Mohsen Amini
Journal:  Iran J Pharm Res       Date:  2015       Impact factor: 1.696

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.